Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00230347
Status:
COMPLETED
Last Update Posted:
2010-04-01
First Post:
2005-09-28
Brief Title:
Evaluation of Stereotactic Radiosurgery For Liver Malignancies
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Dose Escalation Study Evaluating Stereotactic Radiosurgery for Liver Malignancies
Status:
COMPLETED
Status Verified Date:
2010-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is intended to establish the practicality of treating cancer in the liver with precisely administered single fractions of high-energy radiation using a radiosurgical cross-firing technique A second purpose is to establish a safe dose for such therapy Finally the efficacy of radiosurgical ablation of liver tumors in terms of radiographic response will be measured
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NCT00230347 | None | None | None |
| HEP0003 | None | None | None |